Inhibiting cancer growth by targeting the TNFR2 oncogene with TNFR2 antagonistic antibodies

被引：0
|
作者：
Torrey, Heather
Butterworth, John
Mera, Toshiyuki
Okubo, Yoshiaki
Wang, Limei
Baum, Danielle
Defusco, Audrey
Plager, Sara
Warden, Sarah
Huang, Daniel
Vanamee, Eva
Foster, Rosemary
Faustman, Denise L.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2136
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting the TNFR2 oncogene on tumor cells and tregs of the tumor microenvironment via dominant TNFR2 antagonism.
    Faustman, Denise L.
    Torrey, Heather
    Butterworth, John
    Mera, Toshi
    Okubo, Yoshiaki
    Wang, Limei
    Baum, Danielle
    Warden, Sara
    Plager, Sarah
    Huang, Daniel
    Vanamee, Eva
    Foster, Rosemary
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [2] Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
    Li, Muchun
    Zhang, Xiaozhen
    Bai, Xueli
    Liang, Tingbo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] An immunocytokine consisting of a TNFR2 agonist and TNFR2 scFv enhances the expansion of regulatory T cells through TNFR2 clustering
    Inoue, Masaki
    Tsuji, Yuta
    Kashiwada, Ayaka
    Yokoyama, Asahi
    Iwata, Akane
    Abe, Yasuhiro
    Kamada, Haruhiko
    Tsunoda, Shin-ichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 697
  • [4] Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
    Torrey, Heather
    Butterworth, John
    Mera, Toshiyuki
    Okubo, Yoshiaki
    Wang, Limei
    Baum, Danielle
    Defusco, Audrey
    Plager, Sara
    Warden, Sarah
    Huang, Daniel
    Vanamee, Eva
    Foster, Rosemary
    Faustman, Denise L.
    SCIENCE SIGNALING, 2017, 10 (462)
  • [5] Novel TNFR2 humanized mouse model for human TNFR2 antibody evaluation
    Guo, Yanan
    Li, Yanan
    Zhou, Xiaofei
    Su, Youhong
    Lin, Qingcong
    CANCER RESEARCH, 2020, 80 (16)
  • [6] The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
    Takahashi, Hiroyuki
    Yoshimatsu, Gumpei
    Faustman, Denise Louise
    CELLS, 2022, 11 (12)
  • [7] Targeting TNFR2 in Cancer: All Roads Lead to Rome
    Bai, Jingchao
    Ding, Bowen
    Li, Hui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies
    Torrey, Heather
    Defusco, Audrey
    Baum, Danielle
    Rhabar, Ziba
    Khodadoust, Michael
    Kim, Youn H.
    Faustman, Denise L.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [9] Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies
    Torrey, Heather
    Defusco, Audrey
    Baum, Danielle
    Rahbar, Ziba
    Khodadoust, Michael
    Kim, Youn H.
    Faustman, Denise
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [10] TNFR2: Role in Cancer Immunology and Immunotherapy
    Yang, Yang
    Islam, Md Sahidul
    Hu, Yuanjia
    Chen, Xin
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 103 - 122
12345